Cargando…
Rivaroxaban Treatment for Heparin-Induced Thrombocytopenia: A Case Report and a Review of the Current Experience
Heparin-induced thrombocytopenia is a life-threatening complication of exposure to heparin. Heparin-induced thrombocytopenia results from an autoantibody directed against platelet factor 4 in complex with heparin. Heparin-induced thrombocytopenia is traditionally treated with bivalirudin, argatroban...
Autores principales: | Aon, Mohamed, Al-Shammari, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487115/ https://www.ncbi.nlm.nih.gov/pubmed/32953186 http://dx.doi.org/10.1155/2020/8885256 |
Ejemplares similares
-
Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
Publicado: (2020) -
Rivaroxaban treatment for cancer-associated venous thromboembolism in a patient with heparin-induced thrombocytopenia: a case report
por: Le, Ke-Jia, et al.
Publicado: (2019) -
Rivaroxaban for the treatment of heparin-induced thrombocytopenia with thrombosis in a patient undergoing artificial hip arthroplasty: A case report
por: Lv, Fang-Fang, et al.
Publicado: (2023) -
Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism?
por: Vavlukis, Marija, et al.
Publicado: (2017) -
Heparin: Heparin-induced thrombocytopenia: case report
Publicado: (2020)